You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BRCA 1 protein

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Trial in Tucson, Albuquerque (Pegylated liposomal doxorubicin)

Completed
  • Breast Cancer
  • Pegylated liposomal doxorubicin
  • Tucson, Arizona
  • +1 more
Jan 9, 2023

Ovarian Tumors, BRCA1 Protein, BRCA2 Protein Trial in Worldwide (KU-0059436 (AZD2281)(PARP inhibitor))

Active, not recruiting
  • Ovarian Neoplasms
  • +2 more
  • KU-0059436 (AZD2281)(PARP inhibitor)
  • Brussels, Belgium
  • +4 more
Dec 19, 2022

Breast Cancer, Ovarian Cancer, Breast Tumors Trial in Dnipro, Kyiv (Axitinib)

Enrolling by invitation
  • Breast Cancer
  • +7 more
  • Dnipro, Ukraine
  • +1 more
Jun 17, 2023

Mesothelioma, Malignant Mesothelioma (MM), Early-stage Mesothelioma Trial run by the National Cancer Institute (NCI)

Not yet recruiting
  • Mesothelioma
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 1, 2023

Pancreatic Acinar Cell Carcinoma, Pancreatic Adenocarcinoma, Pancreatic Adenosquamous Carcinoma Trial (Nab paclitaxel,

Not yet recruiting
  • Pancreatic Acinar Cell Carcinoma
  • +6 more
  • Nab paclitaxel
  • +5 more
  • (no location specified)
Oct 30, 2023

BRCA1 Gene Mutation, BRCA2 Gene Mutation, Ovarian Serous Adenocarcinoma Trial in Buffalo, New York (biological, other, drug)

Active, not recruiting
Has Results
  • BRCA1 Gene Mutation
  • +5 more
  • Durvalumab
  • +3 more
  • Buffalo, New York
  • +1 more
Jan 20, 2023

Triple Negative Breast Tumors, Triple Negative Breast Cancer, Breast Tumors Trial (Pembrolizumab, Paclitaxel, Carboplatin)

Not yet recruiting
  • Triple Negative Breast Neoplasms
  • +7 more
  • (no location specified)
Aug 1, 2022

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8

Recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +51 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Mar 15, 2022

Germline Variant Carriers With BRCA1 or BRCA2

Recruiting
  • BRCA1 and/or BRCA2 Variant Carriers
  • +3 more
    • Okayama, Japan
      Okayama University
    Dec 25, 2022

    PREDICTION OF GERMLINE BRCA 1/2 GENES FROM HEALTHY OVARIES

    Not yet recruiting
    • BRCA Mutation
    • +2 more
    • Germinal BRCA
    • (no location specified)
    Mar 3, 2023

    Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Adavosertib)

    Active, not recruiting
    • Advanced Lymphoma
    • +5 more
    • Philadelphia, Pennsylvania
      ECOG-ACRIN Cancer Research Group
    Jun 28, 2022

    Breast Cancer, Ovarian Cancer, Pancreas Cancer Trial (TNG348, Olaparib)

    Not yet recruiting
    • Breast Cancer
    • +7 more
    • (no location specified)
    Sep 26, 2023

    Breast Cancer, Genetic Predisposition Trial in Rome, Varese (Genetic predisposition to breast cancer)

    Recruiting
    • Breast Cancer
    • Genetic Predisposition
    • Genetic predisposition to breast cancer
    • Rome, Italy
    • +1 more
    May 4, 2023

    BRCA and NACT in TNBC Patients

    Completed
    • Triple-Negative Breast Cancer
    • BRCA1/2 genetic testing
    • Rome, RM, Italy
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS
    Feb 20, 2023

    Breast Cancer, Metastatic Breast Cancer, BRCA1 Gene Mutation Trial in Boston (ABT-888, temozolomide)

    Active, not recruiting
    • Breast Cancer
    • +3 more
    • Boston, Massachusetts
    • +2 more
    Dec 21, 2022

    Advanced Malignant Tumor, ATM Gene Mutation, BRCA1 Gene Mutation Trial in Houston (Laboratory Biomarker Analysis,

    Active, not recruiting
    • Advanced Malignant Neoplasm
    • +7 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 21, 2022

    Breast Cancer After Ovarian Cancer During and/or After Therapy:

    Recruiting
    • BRCA-Associated Breast Carcinoma
    • Next-generation sequencing (NGS) assay TruSight Oncology 500 (TSO 500).
    • Rome, RM, Italy
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS
    Mar 9, 2023

    Breast Tumors Trial in Worldwide (KU-0059436 (AZD2281) (PARP inhibitor))

    Completed
    Has Results
    • Breast Neoplasms
    • KU-0059436 (AZD2281) (PARP inhibitor)
    • West Hollywood, California
    • +16 more
    Jan 24, 2023

    BRCA1 Mutation, BRCA2 Mutation, Ovarian Cancer Trial in Providence (Talazoparib Oral Capsule)

    Active, not recruiting
    • BRCA1 Mutation
    • +4 more
    • Talazoparib Oral Capsule
    • Providence, Rhode Island
    • +1 more
    Nov 30, 2022

    Cystatin D Fibrinogen Like Protein 1

    Not yet recruiting
    • Fibrinogen Like Protein 1
    • ELISA TEST
    • (no location specified)
    Jun 26, 2023

    Ultra-rapid BRCA1/2 Status Screening Test in Theranostic

    Not yet recruiting
    • Breast Cancer
    • Questionnaires
    • Communication of the results of the BRCA1/2 ultra rapid test
    • (no location specified)
    Oct 26, 2023

    Dietary Modification, BRCA1 Mutation, BRCA2 Mutation Trial in Milano (Dietary intervention)

    Completed
    • Dietary Modification
    • +3 more
    • Dietary intervention
    • Milano, Italy
      Fondazione IRCCS Istituto Nazionale dei Tumori
    Sep 27, 2021

    Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal

    Not yet recruiting
    • Platinum-Resistant Fallopian Tube Carcinoma
    • +5 more
    • Biopsy
    • +4 more
    • Duarte, California
      City of Hope Medical Center
    Jan 3, 2023

    Metastatic Solid Tumor, BRCA1 Mutation, BRCA2 Mutation Trial in San Francisco (Niraparib, Irinotecan)

    Not yet recruiting
    • Metastatic Solid Tumor
    • +4 more
    • San Francisco, California
      University of California, San Francisco
    Jan 12, 2023

    Stage I Breast Cancer, Stage II Breast Cancer, Stage III Breast Cancer Trial in United States (Niraparib, Dostarlimab)

    Recruiting
    • Stage I Breast Cancer
    • +7 more
    • Baltimore, Maryland
    • +6 more
    Nov 11, 2022